Cost-Related Insulin Rationing in US Adults Younger Than 65 Years With Diabetes
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
This study uses 2021 National Health Interview Survey data to examine the prevalence of insulin rationing among adults younger than 65 years in the US by demographic characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cost-related nonadherence is high at approximately 20% overall”
From Health-Care Utilization and Outcomes in Young Adults With Type 1 and Type 2 Diabetes (2024) · cites this paper as [51]
In the citing paper
“The high cost of insulin is likely a contributing factor to the rise of DKA observed in young adults with DM over the last decade [51].”
From Health-Care Utilization and Outcomes in Young Adults With Type 1 and Type 2 Diabetes (2024) · cites this paper as [51]
In the citing paper
“Among young adults, 90% endorsed worry about DM costs”
From Health-Care Utilization and Outcomes in Young Adults With Type 1 and Type 2 Diabetes (2024) · cites this paper as [51]
In the citing paper
“those endorsing concern about DM costs were far less likely to achieve target HbA1c (50% vs 93.6%)”
From Health-Care Utilization and Outcomes in Young Adults With Type 1 and Type 2 Diabetes (2024) · cites this paper as [51]
In the citing paper
“and close to 30% in uninsured individuals with DM [51]”
From Health-Care Utilization and Outcomes in Young Adults With Type 1 and Type 2 Diabetes (2024) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benoit, S. R., Hora, I., Pasquel, F. J., Gregg, E. W., Albright, A. L., & Imperatore, G. (2020) · Diabetes Care · doi:10.2337/dc19-2449 · Cited by 117
Research works printed but not linked: 3
- Gaffney, 2022, Prevalence and correlates of patient rationing of insulin in the united states: a national survey., Ann Intern Med, 175, 1623, 10.7326/M22-2477 · DOI · Paper page
- Selvin, 2016, Trends in insulin use and diabetes control in the US: 1988–1994 and 1999–2012., Diabetes Care, 39, e33, 10.2337/dc15-2229 · DOI · Paper page
- Sanofi cuts US list price of Lantus, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance. News release. Sanofi. Accessed March 16, 2023. https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-16-20-06-43-2629188
Cited by
Hyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
Health-Care Utilization and Outcomes in Young Adults With Type 1 and Type 2 Diabetes
Zenno, A., Huang, A., Roberts, A. J., & Pihoker, C. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae115 · Cited by 2
Metadata
- Authors
- Fang, M., & Selvin, E.
- Affiliations
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2023-05-16
- Volume
- 329
- Issue
- 19
- Pages
- 1700
- ISSN
- 0098-7484
- Cited by
- 21
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-Related Insulin Rationing in US Adults Younger Than 65 Years With Diabetes. https://app.cochat.ai/papers/10.1001/jama.2023.5747
- The paper
- Fang, M., & Selvin, E. (2023). Cost-Related Insulin Rationing in US Adults Younger Than 65 Years With Diabetes. JAMA. https://doi.org/10.1001/jama.2023.5747
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.